Zentalis Pharmaceuticals Inc ZNTL

NAS: ZNTL | ISIN: US98943L1070 30/04/2025

1,420 USD (+3,65%)

(+3,65%) 30/04/2025

Grafiek Zentalis Pharmaceuticals Inc

Grafiek Zentalis Pharmaceuticals Inc

1 dag1d 3,65%
1 week1w -5,96%
1 maand1m 2,16%
3 maanden3m -15,48%
6 maanden6m -57,23%
1 jaar1j -87,44%
5 jaar5j -95,46%

Zentalis Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

29 december 2022 · Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm · Persbericht

10 maart 2021 · Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021 · Persbericht

24 februari 2021 · Zentalis Pharmaceuticals to Present Initial Clinical Data on ZN-c3 at the AACR Annual Meeting 2021 · Persbericht

10 februari 2021 · Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors · Persbericht

5 februari 2021 · Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences · Persbericht

Profiel Zentalis Pharmaceuticals Inc

Beleggingstrusts/Mutual Funds

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: zentalis.com

Hoofdzetel: New York, NY Verenigde Staten

CEO: Kimberly Lynn Blackwell

Werknemers: 166

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe